Region:Middle East
Author(s):Geetanshi
Product Code:KRAA6072
Pages:93
Published On:January 2026

By Type:The market is segmented into various types of diagnostic devices, including Blood Glucose Monitoring Devices, Infectious Disease Testing Kits, Cardiac Markers Testing Devices, Coagulation Testing Devices, Pregnancy and Fertility Testing Kits, and Others. Among these, Blood Glucose Monitoring Devices are leading the market due to the rising incidence of diabetes and the growing need for self-monitoring among patients. The convenience and ease of use of these devices have made them a preferred choice for both healthcare providers and patients.

By End-User:The end-user segmentation includes Hospitals, Diagnostic Laboratories, Home Care Settings, Urgent Care Centers, and Others. Hospitals are the dominant end-user segment, driven by the increasing number of patients requiring immediate diagnostic results for effective treatment. The integration of POC diagnostics in hospital settings enhances patient care by facilitating timely decision-making and improving overall healthcare outcomes.

The Bahrain Point of Care POC Diagnostics Market is characterized by a dynamic mix of regional and international players. Leading participants such as Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Becton, Dickinson and Company, Cepheid, Alere Inc., Quidel Corporation, Bio-Rad Laboratories, Hologic, Inc., Thermo Fisher Scientific, Medtronic, Ortho Clinical Diagnostics, GenMark Diagnostics, Point of Care Diagnostics, Inc., AccuBioTech contribute to innovation, geographic expansion, and service delivery in this space.
The future of the POC diagnostics market in Bahrain appears promising, driven by increasing healthcare investments and a shift towards personalized medicine. The integration of artificial intelligence in diagnostic processes is expected to enhance accuracy and efficiency, while the expansion of telemedicine services will facilitate remote patient monitoring. As healthcare providers increasingly prioritize rapid testing solutions, the market is likely to witness significant growth, fostering innovation and improving patient outcomes across the region.
| Segment | Sub-Segments |
|---|---|
| By Type | Blood Glucose Monitoring Devices Infectious Disease Testing Kits Cardiac Markers Testing Devices Coagulation Testing Devices Pregnancy and Fertility Testing Kits Others |
| By End-User | Hospitals Diagnostic Laboratories Home Care Settings Urgent Care Centers Others |
| By Application | Disease Diagnosis Health Monitoring Emergency Care Others |
| By Distribution Channel | Direct Sales Online Sales Distributors Others |
| By Technology | Lateral Flow Assays Microfluidics Molecular Diagnostics Others |
| By Region | Northern Governorate Southern Governorate Capital Governorate Muharraq Governorate Others |
| By Policy Support | Government Subsidies Tax Incentives Research Grants Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Hospital POC Diagnostic Usage | 100 | Clinical Laboratory Managers, Hospital Administrators |
| Private Clinic Adoption of POC Tests | 75 | General Practitioners, Clinic Owners |
| Pharmacy-Based POC Testing | 50 | Pharmacists, Pharmacy Managers |
| Home Healthcare POC Diagnostics | 60 | Home Health Aides, Patient Care Coordinators |
| Public Health Initiatives and POC Testing | 80 | Public Health Officials, Epidemiologists |
The Bahrain Point of Care POC Diagnostics Market is valued at approximately USD 145 million, reflecting a significant growth driven by the rising prevalence of chronic diseases and the demand for rapid diagnostic tests.